BNP Paribas Financial Markets
ASPX

BNP Paribas Financial Markets’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

BNP Paribas Financial Markets’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-206
Closed -$20.7K – 3746
2015
Q1 		$20.7K Buy
+206
New +$13.7K ﹤0.01% 2353
2014
Q4 		– Sell
-675
Closed -$17.3K – 4031
2014
Q3 		$17.3K Buy
675
+390
+137% +$8.3K ﹤0.01% 3271
2014
Q2 		$6.35K Buy
+285
New +$6.24K ﹤0.01% 2479

BNP Paribas Financial Markets's ASPX Position: Q2 2015 in Review

BNP Paribas Financial Markets sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 206 shares — an estimated $20.7K sold.

BNP Paribas Financial Markets first reported a position in ASPX in Q2 2014 and held it in 3 quarters. The position peaked at $20.7K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • BNP Paribas Financial Markets reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 206 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $20.7K.
  • BNP Paribas Financial Markets first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 3 quarters.
  • BNP Paribas Financial Markets's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $20.7K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.